The ECS is one of the most widespread neuromodulatory systems in the body — present in virtually every organ. It maintains homeostasis by regulating mood, memory, appetite, pain, immune function, and sleep through retrograde synaptic signaling.
Unlike classical neurotransmitters that travel forward from presynaptic to postsynaptic neurons, endocannabinoids are synthesized on demand in the postsynaptic neuron and travel backwards — suppressing excess neurotransmitter release upstream. This "retrograde inhibition" makes the ECS a master regulator of synaptic tone across virtually every major neural circuit.
Modulate neurotransmitter release — primarily inhibitory. Dense in hippocampus (memory), amygdala (fear/emotion), basal ganglia (motor), prefrontal cortex (executive function). THC binds here, producing psychoactive effects.
Primarily regulate immune function and inflammation. Low density in the brain under normal conditions but upregulate during neuroinflammation — making them a key target for neuroprotective therapies without psychoactive effects.
Activated by CBD and anandamide at high concentrations. Involved in pain modulation, body temperature regulation, and inflammation. CBD's interaction here partly explains its analgesic properties.
Phytocannabinoids (plant-derived, e.g. THC, CBD) interact with the same receptors as our endogenous cannabinoids. THC is a partial CB1 agonist — it mimics anandamide but with higher potency and longer duration. CBD does not directly bind CB1/CB2 with high affinity; instead it modulates the ECS indirectly by inhibiting the enzyme FAAH, which breaks down anandamide — effectively raising your brain's own endocannabinoid tone.